Subcortical gray matter changes in pediatric patients with new-onset juvenile myoclonic epilepsy

Zeynep Öztürk1, Altan Güneş2, Zeynep Selen Karalok3

  • 1Department of Pediatric Neurology, Ankara Children's Hematology-Oncology Training and Research Hospital, Ankara, Turkey,.

Epilepsy & Behavior : E&B
|January 15, 2020
PubMed
Abstract

Insights

Juvenile myoclonic epilepsy (JME) is associated with reduced thalamic gray matter volumes, indicating early microstructural abnormalities. These findings suggest the thalamus plays a critical role in JME pathogenesis.

Area of Science:

  • Neuroscience
  • Neurology
  • Radiology

Background:

  • Juvenile myoclonic epilepsy (JME) is a common epilepsy syndrome.
  • Understanding the neurobiological underpinnings of JME is crucial for effective treatment.

Purpose of the Study:

  • To investigate the relationship between subcortical gray matter (GM) volumes and JME.
  • To identify potential structural brain abnormalities associated with JME at disease onset.

Main Methods:

  • Brain magnetic resonance imaging (MRI) scans of drug-naïve patients with JME, generalized tonic-clonic seizures alone (GTCS), and healthy controls (HCs) were analyzed.
  • Voxel-based morphometry (VBM) and volumetric analysis were used to measure subcortical GM volumes, including the thalamus, caudate nucleus, pallidum, and putamen.
  • Statistical comparisons were performed among the JME, GTCS, and HC groups.

Main Results:

  • No significant differences in relative globus pallidus, caudate, or putamen volumes were found among the groups.
  • Significantly lower relative left and right thalamic volumes were observed in patients with JME compared to both HCs and patients with GTCS.
  • No significant differences in thalamic volumes were found between HCs and patients with GTCS.

Conclusions:

  • Microstructural abnormalities, specifically reduced thalamic volumes, are present at the onset of JME.
  • The thalamus appears to play a critical role in the pathogenesis of JME.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.2K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
820
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K